You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

thyroid carcinoma of follicular origin

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

Completed
  • Huerthle Cell Carcinoma
    • (no location specified)
    Jul 20, 2023

    Radioiodine Planar andSPECT/CT Imaging With Iodine-123 for

    Recruiting
    • Thyroid Gland Follicular Carcinoma
    • Computed Tomography
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

    Active, not recruiting
    • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
    • +25 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Torrance, California
    • +6 more
    Jan 12, 2023

    Surgical Management of Advanced Thyroid Cancer

    Recruiting
    • Thyroid Carcinoma
    • +6 more
    • Thyroidectomy with or without lymphadenectomy or multivisceral resection
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Mar 31, 2023

    18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

    Recruiting
    • Differentiated Thyroid Gland Carcinoma
    • +2 more
    • Computed Tomography
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

    Not yet recruiting
    • Thyroid Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 20, 2022

    Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma

    Recruiting
    • Refractory Thyroid Gland Carcinoma
    • +3 more
    • 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
    • +2 more
    • Xiamen, China
      The First Affiliated Hospital of Xiamen University
    Nov 3, 2022

    Benign Thyroid Gland Tumor, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential

    Recruiting
    • Benign Thyroid Gland Neoplasm
    • +4 more
    • Quality-of-Life Assessment
    • Radiofrequency Ablation
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 3, 2022

    Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

    Recruiting
    • Thyroid Cancer
    • +6 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 19, 2023

    Thyroid Carcinoma, Thyroid Cancer, Thyroid Cancer, Follicular Trial in United States (I-124 PET/CT lesion dosimetry,

    Recruiting
    • Thyroid Carcinoma
    • +5 more
    • I-124 PET/CT lesion dosimetry
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Mar 3, 2022

    Metastatic Thyroid Papillary Carcinoma, Metastatic Thyroid Follicular Carcinoma, Metastatic Thyroid Cancer Trial in Spain

    Recruiting
    • Metastatic Thyroid Papillary Carcinoma
    • +2 more
    • L'Hospitalet de Llobregat, Barcelona, Spain
    • +14 more
    Feb 18, 2022

    Carcinoma, Papillary, Follicular Trial in Seoul (Using Neuromonitoring to find EBSLN)

    Terminated
    • Carcinoma, Papillary, Follicular
    • Using Neuromonitoring to find EBSLN
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jan 13, 2022

    Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

    Terminated
    Has Results
    • Thyroid Cancer
    • +5 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jul 12, 2021

    Thyroid Cancer Trial

    Completed
    • Thyroid Cancer
      • (no location specified)
      Jul 2, 2021

      Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma Trial in Atlanta

      Terminated
      • Differentiated Thyroid Gland Carcinoma
      • +2 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Jun 25, 2021

      Thyroid Tumors Trial in Worldwide (Vandetanib, Placebo)

      Active, not recruiting
      Has Results
      • Thyroid Neoplasms
      • Brussels, Belgium
      • +21 more
      Oct 20, 2021

      Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland

      Completed
      Has Results
      • Refractory Differentiated Thyroid Gland Carcinoma
      • +4 more
      • Duarte, California
      • +32 more
      Jun 24, 2021

      Galectin-3 in Papillary Thyroid Carcinoma

      Not yet recruiting
      • Galactin 3-thyroid Carcinoma
        • (no location specified)
        Jan 26, 2023

        Thyroid Tumors Trial in Lexington (Lenalidomide)

        Completed
        Has Results
        • Thyroid Neoplasms
        • Lexington, Kentucky
          University of Kentucky Markey Cancer Center
        May 28, 2020

        Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

        Recruiting
        • Thyroid Cancer
        • +2 more
          • Taipei, Taiwan
            Chih-Yuan Wang, M.D
          Oct 16, 2022

          Indeterminate Thyroid Nodules Through Integration of Clinical,

          Not yet recruiting
          • Thyroid Nodule
          • Thyroid Cancer
          • Multiomic analyses of blood and surgical specimens
          • Cagliari, CA, Italy
            AOU Cagliari
          Jun 16, 2022

          Assessment of CA 19-9 in Patients' With Thyroid Malignancies

          Not yet recruiting
          • Thyroid Cancer
          • Laboratory investigations for control: a-Complete blood count. b-Liver function test. c-kidney function test. d-thyroid-stimulating hormone,T3 and T4. e-Assessment of levels of CA19-9.
          • Sohag, Egypt
            Sohag faculty of medicine
          Nov 6, 2021

          Thyroid Cancer Trial in Bron cedex (follow up visit)

          Active, not recruiting
          • Thyroid Cancer
          • follow up visit
          • Bron cedex, France
            Hospices Civils de Lyon-Centre de Médecine Nucléaire Groupement
          Jan 26, 2021

          Differentiated Thyroid Cancer Patients Treated With Different

          Not yet recruiting
          • Thyroid Cancer
          • (no location specified)
          Nov 15, 2023

          Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

          Recruiting
          • Thyroid Cancer
          • NTRK fusion assessment
          • Roma, Italy
            Regina Elena National Cancer Institute
          Mar 31, 2023